AROC.NYSEArchrock, INC

Form 4: Archrock Director Lytal Receives Restricted Stock Grant

Sentiment:

Insider Transaction Report


Archrock, Inc. Director James H. Lytal was granted 5,313 shares of restricted common stock, vesting through December 2026.

Summary

  • James H. Lytal, a Director of Archrock, Inc. (AROC), was granted 5,313 shares of common stock.
  • The grant represents restricted stock issued under the Archrock, Inc. 2020 Stock Incentive Plan.
  • The shares were acquired at a price of $0, indicating an award rather than a purchase.
  • Following this transaction, Lytal beneficially owns a total of 131,728 shares of Archrock common stock.
  • The award is subject to a vesting schedule: 25% vests on the grant date (January 29, 2026), and subsequent 25% tranches vest on June 1, September 1, and December 1, 2026.
  • The award is also subject to forfeiture or accelerated vesting based on specific events outlined in the Award Notice and Agreement.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard director compensation practices that align management incentives with shareholder interests, without indicating any significant operational or financial shifts.

Positives

  • The grant of restricted stock to Director James H. Lytal aligns his financial interests with those of shareholders, promoting long-term value creation and commitment.
  • The increase in beneficial ownership to 131,728 shares demonstrates continued investment and confidence from a key member of the board.

Future Outlook

The restricted stock grant to Director James H. Lytal is structured with a vesting schedule extending through 2026, with 25% vesting on the grant date (January 29, 2026), and subsequent 25% tranches on June 1, September 1, and December 1, 2026. This indicates a planned long-term incentive and retention strategy for the director.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common form of executive and director compensation in the energy services sector, particularly for companies like Archrock, which operates in natural gas compression. These grants are designed to align the interests of leadership with long-term shareholder value, a standard practice across the industry.

Comparison to Industry Standards

  • The grant of restricted stock at a $0 price is a standard practice for equity compensation plans across publicly traded companies, including those in the energy sector.
  • The vesting schedule, with quarterly tranches over a year, is a common approach to retain key personnel and incentivize sustained performance, comparable to practices at peers like USA Compression Partners (USAC) or Exterran Corporation (EXTN) before its merger.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Authorization of Attorney-in-FactJames H. Lytal granted a Power of Attorney to Stephanie C. Hildebrandt, Andrew Gratz, and William P. Bowes, Jr. to execute and file Section 16 forms (Forms 3, 4, and 5) on his behalf.2025-04-24Streamlines compliance with SEC reporting requirements for insider transactions, ensuring timely and accurate filings.

Related Party Transactions

  • The grant of 5,313 shares of restricted common stock to James H. Lytal, a Director of Archrock, Inc., constitutes a related party transaction as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

  • Shareholders: The restricted stock grant aligns the director's financial interests with long-term shareholder value, potentially fostering more strategic decision-making.
  • Employees: While not directly impacting general employees, such compensation practices for directors are part of the overall corporate governance and incentive structure.

Next Steps

  • Vesting of 25% of the restricted stock on June 1, 2026.
  • Vesting of 25% of the restricted stock on September 1, 2026.
  • Vesting of 25% of the restricted stock on December 1, 2026.

Key Dates

DateDescription
2025-04-24Effective date of the Power of Attorney authorizing designated individuals to execute Section 16 filings on behalf of James H. Lytal.
2026-01-29Transaction date for the restricted stock grant and the initial 25% vesting of the award.
2026-02-02Date the Form 4 was signed by the attorney-in-fact.
2026-06-01Second 25% vesting date for the restricted stock award.
2026-09-01Third 25% vesting date for the restricted stock award.
2026-12-01Final 25% vesting date for the restricted stock award.

Recommendation

hold

This Form 4 filing reports a routine restricted stock grant to a director, which is a standard compensation practice. It does not contain information significant enough to warrant a change in investment recommendation, thus a 'hold' stance is maintained as it reflects normal course of business.

Keywords

Archrock, AROC, Form 4, Insider Transaction, Restricted Stock, Stock Grant, Director Compensation, Equity Incentive Plan, Beneficial Ownership, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.